Table 6. Mutations (including Missense point mutations/deletion/insertion) frequencies in 45 genes (737 loci) of human lung cancer samples from heavy smokers (smoking index> = 400), light smokers (smoking index<400) and non-smokers.
Genes | Number of samples with mutations in 76 samples (Mutation frequency) | Number of samples of heavy smokers with mutations (Mutation frequency in 17 samples) | Number of samples of light smokers samples with mutations (Mutation frequency in 6 samples) | Number of samples of non-smoker samples with mutations (Mutation frequency in 52 samples) | Number of unknown samples with mutations (Mutation frequency in 1 sample) |
ABL1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
AKT1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
ALK | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
APC | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
ATM | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
BRAF | 2(2.6%) | 1(5.9%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
CDH1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
CDKN2A | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
CSF1R | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
CTNNB1 | 3(3.9%) | 0(0.0%) | 0(0.0%) | 3(5.8%) | 0(0.0%) |
EGFR | 32(42.1%) | 3(17.6%) | 2(33.3%) | 27(51.9%) | 0(0.0%) |
ERBB2 | 1(1.3%) | 0(0.0%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
ERBB4 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
FBXW7 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
FGFR1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
FGFR2 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
FGFR3 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
FLT3 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
GNAS | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
HNF1A | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
HRAS | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
IDH1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
JAK3 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
KDR | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
KIT | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
KRAS | 4(5.3%) | 3(17.6%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
MET | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
MLH1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
MPL | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
NOTCH1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
NPM1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
NRAS | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
PDGFRA | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
PIK3CA | 2(2.6%) | 1(5.9%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
PTEN | 1(1.3%) | 0(0.0%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
PTPN11 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
RB1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
RET | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
SMAD4 | 1(1.3%) | 0(0.0%) | 0(0.0%) | 1(1.9%) | 0(0.0%) |
SMARCB1 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
SMO | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
SRC | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
STK11 | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
TP53 | 17(22.4%) | 7(41.2%) | 1(16.7%) | 9(17.3%) | 0(0.0%) |
VHL | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |